Institut Catala dOncologia

L'Hospitalet de Llobregat 08908

1 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Newly Diagnosed Glioblastoma

Studies at this site

• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now
• Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04) — Running, not enrolling
• A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma — Completed